An Atlantic City, N.J., jury has socked Swiss pharmaceutical giant Roche Holding AG with another big verdict involving its potent acne medication, Accutane, this one to the tune of $25.16 million.
That’s how much the jury on Feb. 16 ordered the company to pay Andrew McCarrell, a computer technician from Birmingham, Ala., who took Accutane in his 20s and consequently developed inflammatory bowel disease, ultimately forcing him to have his colon removed. Accutane was made by the company’s Hoffmann-La Roche unit in Nutley, N.J., before it was taken off the market this past June.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
